Generic medications contain the same active ingredients and work the same way as brand-name medications, but cost substantially less. As many Americans face mounting healthcare costs, substituting generic medications for their brand name counterparts can result in considerable savings for patients and payers. Researchers at the University of Chicago recently analyzed the generic substitution rates of oral contraceptives (OCPs) and the associated costs in the U.S for the period of January 2010-December 2014. While the rates of prescribing generic OCPs increased during this period, there was no decrease in the costs associated with brand OCPs. In most cases, brand OCPs … Read More

President Robert Zimmer recently awarded named professorships to two Department of Medicine physician scientists: Bana Jabri, MD,PhD (Gastroenterology, Hepatology & Nutrition) and Louis H. Philipson, MD, PhD ( Endocrinology, Diabetes & Metabolism) effective January 1, 2018.   Dr. Jabri, a world expert in celiac disease, has been named as Sarah and Harold Lincoln Thompson Professor, and Louis Philipson, MD, PhD, an internationally recognized expert on the biophysics of insulin secretion whose innovative work has significantly impacted clinical outcomes of patients with diabetes, has been named the inaugural James C. Tyree Professor of Diabetes Research and Care. Dr. Jabri is a world leader … Read More

A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health care costs over their average lifetime when compared with treatment strategies that stick to a uniform national standard. More

The University of Chicago Medicine celebrated the completion of what will be the city’s newest and most advanced adult emergency department when the $39 million facility opens to patients in late December.  More than 150 people, including public officials, community representatives and faith leaders, were on hand for the Dec. 5 celebration, which included a ribbon-cutting ceremony and community tours of the new state-of-the-art emergency department.  More

The FDA approved a breakthrough cancer treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma, that uses genetically engineered immune cells to target cancer. More…

Marshall Chin, MD, Richard Parrillo Family Professor of Healthcare Ethics, has been elected to the National Academy of Medicine. This prestigious honor reflects his extraordinary contributions towards improving the care and outcomes for vulnerable patients with chronic disease and reducing health disparities. Dr. Chin joins five faculty from the Department of Medicine, Graeme Bell, PhD, Robert Gibbons, PhD, David Meltzer, MD, PhD, Olufunmilayo Olopade, MD, and Kenneth Polonsky, MD, as elected members of NAM.   Dr. Chin received his MD from the University of California at San Francisco in 1989, followed by his primary care residency training at Brigham and … Read More

Check out the 2017 Department of Medicine Annual Report entitled “Powerful Connections”. You can view the annual report by clicking the link here.